Reduction of Liver Fibrosis by Rationally Designed Macromolecular Telmisartan Prodrugs
Nature Biomedical Engineering - United States
doi 10.1038/s41551-018-0279-x
Full Text
Open PDFAbstract
Available in full text
Date
August 20, 2018
Authors
Publisher
Springer Science and Business Media LLC